Skip to content
PICO Portalanswers from OpenAlex

Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside

PaperCitations, authors & open-access status

Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside is a paper indexed in PICO Portal from OpenAlex.

How many citations does Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside have?

PICO Portalcitation count

Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside has 88 citations in the OpenAlex counts PICO Portal stores.

When was Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside published?

PICO Portalyear

Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside has 2012 year in the PICO Portal index.

What is the open-access status of Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside?

PICO Portaloa status

Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside has green oa status in the PICO Portal index.

What is the DOI of Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside?

PICO Portaldoi

The DOI for Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside is on the source record.

What is the PMID of Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside?

PICO Portalpmid

The PMID for Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside is on the source record.

What is the OpenAlex record for Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside?

PICO Portalopenalex

The OpenAlex for Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial